U.S. federal trademark · Serial No. 77077112 · Reg. No. 3521274
genetic medicines, namely, retroviral-based and lentiviral-based genetic medicines for the treatment of HIV; gene therapy products, namely, biological vector transport systems which incorporate genetic payloads comprising nucleic acids; pharmaceutical preparations for the treatment of HIV
chemical reagents for scientific, medical research or laboratory use; reagents for use in genetic research; biological vector transport systems that incorporate genetic payloads comprising nucleic acids for use in research
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.